XML 27 R6.htm IDEA: XBRL DOCUMENT v3.24.0.1
UNAUDITED CONSOLIDATED STATEMENTS OF SHAREHOLDERS' EQUITY - USD ($)
shares in Thousands, $ in Millions
Total
Cumulative Effect, Period of Adoption, Adjustment
Common Stock
Additional Paid-in Capital
Additional Paid-in Capital
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Deficit
Accumulated Deficit
Cumulative Effect, Period of Adoption, Adjustment
Accumulated Other Comprehensive Loss
Balance at beginning of period (in shares) at Jun. 26, 2022     123,795          
Balance at beginning of period at Jun. 26, 2022 $ 2,439.3 $ (303.3) $ 0.2 $ 4,228.4 $ (333.0) $ (1,764.0) $ 29.7 $ (25.3)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (26.2)         (26.2)    
Unrealized gain on available-for-sale securities (7.0)             (7.0)
Tax withholding on vested equity awards (16.9)     (16.9)        
Stock-based compensation (in shares)     395          
Stock-based compensation 23.2     23.2        
Exercise of stock options and issuance of shares (in shares)     20          
Exercise of stock options and issuance of shares 0.5     0.5        
Balance at end of period (in shares) at Sep. 25, 2022     124,210          
Balance at end of period at Sep. 25, 2022 2,109.6   $ 0.2 3,902.2   (1,760.5)   (32.3)
Balance at beginning of period (in shares) at Jun. 26, 2022     123,795          
Balance at beginning of period at Jun. 26, 2022 2,439.3 $ (303.3) $ 0.2 4,228.4 $ (333.0) (1,764.0) $ 29.7 (25.3)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (117.1)              
Unrealized gain on available-for-sale securities (3.3)              
Balance at end of period (in shares) at Dec. 25, 2022     124,413          
Balance at end of period at Dec. 25, 2022 $ 1,780.2   $ 0.2 3,660.0   (1,851.4)   (28.6)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Adoption of ASU 2020-06 [Extensible Enumeration] Accounting Standards Update 2020-06 [Member]              
Balance at beginning of period (in shares) at Sep. 25, 2022     124,210          
Balance at beginning of period at Sep. 25, 2022 $ 2,109.6   $ 0.2 3,902.2   (1,760.5)   (32.3)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (90.9)         (90.9)    
Unrealized gain on available-for-sale securities 3.7             3.7
Tax withholding on vested equity awards (0.4)     (0.4)        
Stock-based compensation 21.4     21.4        
Exercise of stock options and issuance of shares (in shares)     203          
Exercise of stock options and issuance of shares 10.7     10.7        
Capped call transactions related to the issuance of convertible notes due December 1, 2029 (273.9)     (273.9)        
Balance at end of period (in shares) at Dec. 25, 2022     124,413          
Balance at end of period at Dec. 25, 2022 $ 1,780.2   $ 0.2 3,660.0   (1,851.4)   (28.6)
Balance at beginning of period (in shares) at Jun. 25, 2023 124,794   124,794          
Balance at beginning of period at Jun. 25, 2023 $ 1,621.9   $ 0.2 3,711.0   (2,064.2)   (25.1)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (395.7)         (395.7)    
Unrealized gain on available-for-sale securities 1.9             1.9
Tax withholding on vested equity awards (15.0)     (15.0)        
Stock-based compensation (in shares)     506          
Stock-based compensation 32.1     32.1        
Exercise of stock options and issuance of shares (in shares)     21          
Exercise of stock options and issuance of shares 0.5     0.5        
Balance at end of period (in shares) at Sep. 24, 2023     125,321          
Balance at end of period at Sep. 24, 2023 $ 1,245.7   $ 0.2 3,728.6   (2,459.9)   (23.2)
Balance at beginning of period (in shares) at Jun. 25, 2023 124,794   124,794          
Balance at beginning of period at Jun. 25, 2023 $ 1,621.9   $ 0.2 3,711.0   (2,064.2)   (25.1)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (540.4)              
Unrealized gain on available-for-sale securities $ 12.9              
Balance at end of period (in shares) at Dec. 31, 2023 125,785   125,785          
Balance at end of period at Dec. 31, 2023 $ 1,150.2   $ 0.2 3,766.8   (2,604.6)   (12.2)
Balance at beginning of period (in shares) at Sep. 24, 2023     125,321          
Balance at beginning of period at Sep. 24, 2023 1,245.7   $ 0.2 3,728.6   (2,459.9)   (23.2)
Increase (Decrease) in Stockholders' Equity [Roll Forward]                
Net loss (144.7)         (144.7)    
Unrealized gain on available-for-sale securities 11.0             11.0
Tax withholding on vested equity awards (2.0)     (2.0)        
Stock-based compensation (in shares)     104          
Stock-based compensation 29.8     29.8        
Exercise of stock options and issuance of shares (in shares)     360          
Exercise of stock options and issuance of shares $ 10.4     10.4        
Balance at end of period (in shares) at Dec. 31, 2023 125,785   125,785          
Balance at end of period at Dec. 31, 2023 $ 1,150.2   $ 0.2 $ 3,766.8   $ (2,604.6)   $ (12.2)